ARCHIVES

NMP22 Assay More Effective Than Conventional Lab Test

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Offers Model Informed Consent Documents

November 6, 1998

In Brief: Nabel To Direct Vaccine Research Center; Former NIH Director Robert Marston Is Dead

March 19, 1999

Institute of Medicine Elects 70 Members at Annual Meeting

October 25, 2013

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

ACCC Members Hear How Community Cancer Programs Are Developed

February 11, 1977

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011